A Prospective, obServational pOst maRketing survEillance study to evAluate the effectiveness and safety of secukinumab in Indian patients with moderate to severe pLaque psoriasis requiring systemic therapy (PSO-REAL Study) - PSO-REAL study

Trial Profile

A Prospective, obServational pOst maRketing survEillance study to evAluate the effectiveness and safety of secukinumab in Indian patients with moderate to severe pLaque psoriasis requiring systemic therapy (PSO-REAL Study) - PSO-REAL study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms PSO-REAL
  • Sponsors Novartis
  • Most Recent Events

    • 03 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 14 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top